Page last updated: 2024-12-06

2-ethoxy ethyl methacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Ethoxy Ethyl Methacrylate (EEMA) is a monomer used in the synthesis of polymers. It is a colorless liquid with a mild odor. EEMA is synthesized by the reaction of methacrylic acid with 2-ethoxyethanol in the presence of a catalyst. EEMA is known for its ability to form polymers with good adhesion, flexibility, and resistance to chemicals. These properties make EEMA valuable in various applications, including adhesives, coatings, and sealants. The study of EEMA focuses on its polymerization behavior, the properties of its polymers, and the potential applications of these polymers. EEMA is also being studied for its potential use in biomedical applications, such as drug delivery and tissue engineering.'

2-ethoxy ethyl methacrylate: RN given refers to monomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71404
CHEMBL ID1414186
SCHEMBL ID36524
MeSH IDM0093426

Synonyms (44)

Synonym
unii-5q6xr4mr8e
5q6xr4mr8e ,
2-propenoic acid, 2-methyl-, 2-ethoxyethyl ester
2-ethoxyethyl methacrylate
ethoxyethyl methacrylate
nsc-24162
nsc24162
2370-63-0
methacrylic acid, 2-ethoxyethyl ester
2-(ethyloxy)ethyl 2-methylprop-2-enoate
NCGC00166254-01
2-ethoxyethyl methacrylate, contains 100 ppm hydroquinone monomethyl ether as inhibitor, 99%
nsc 24162
2-ethoxy ethyl methacrylate
einecs 219-135-3
51289-08-8
2-ethoxyethyl 2-methylprop-2-enoate
methacrylic acid 2-ethoxyethyl ester
ethylene glycol monoethyl ether methacrylate
M1251
NCGC00260360-01
cas-2370-63-0
dtxcid202186
dtxsid1022186 ,
tox21_202814
AKOS015912731
ethoxyethyl methacrylate [inci]
.beta.-ethoxyethyl methacrylate
acryester et
ethanol, 2-ethoxy-, methacrylate
SCHEMBL36524
2-ethoxyethyl 2-methylacrylate #
W-109774
CHEMBL1414186
mfcd00009249
2-ethoxyethyl methacrylate, (stabilized with mehq)
2-ethoxyethyl methacrylate (stabilized with mehq)
FT-0720731
ethoxyethylmethacrylate
Q27262728
BS-52221
STARBLD0019598
CAA37063
F71270

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The lack of toxicity in these specimens suggests that residual contents of inhibitor and initiator are too low to cause toxic effects on choroidal fibroblasts."( Cytotoxic effects of residual chemicals from polymeric biomaterials for artificial soft intraocular lenses.
Barrett, GD; Chirila, TV; Constable, IJ; Thompson, DE; Walker, LN, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency0.77270.000714.592883.7951AID1259369
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency42.73340.001022.650876.6163AID1224838; AID1224839
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency1.54180.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.70440.000229.305416,493.5996AID1259244
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency49.20000.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency101.20600.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency125.89200.010039.53711,122.0200AID1479
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency54.70440.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency54.70440.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.57 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]